L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons

Stroke. 1998 Jan;29(1):196-201; discussion 202. doi: 10.1161/01.str.29.1.196.

Abstract

Background and purpose: Experimental evidence supports a major role of increased intracellular calcium [Ca2+]i levels in the induction of neuronal damage during cerebral ischemia. However, the source of Ca2+ rise has not been fully elucidated. To clarify further the role and the origin of Ca2+ in cerebral ischemia, we have studied the effects of various pharmacological agents in an in vitro model of oxygen (O2)/glucose deprivation.

Methods: Pyramidal cortical neurons were intracellularly recorded from a slice preparation. Electrophysiological recordings and microfluorometric measurements of [Ca2+]i were performed simultaneously in slices perfused with a glucose-free physiological medium equilibrated with a 95% N2/5% CO2 gas mixture.

Results: Eight to twelve minutes of O2/glucose deprivation induced an initial membrane hyperpolarization, followed by a delayed, large but reversible membrane depolarization. The depolarization phase was accompanied by a transient increase in [Ca2+]i levels. When O2/glucose deprivation exceeded 13 to 15 minutes, both membrane depolarization and [Ca2+]i rise became irreversible. The dihydropyridines nifedipine and nimodipine significantly reduced either the membrane depolarization or the [Ca2+]i elevation. In contrast, tetrodotoxin had no effect on either of these parameters. Likewise, antagonists of ionotropic and group I and II metabotropic glutamate receptors failed to reduce the depolarization of the cell membrane and the [Ca2+]i accumulation. Finally, dantrolene, blocker of intracellular Ca2+ release, did not reduce both electrical and [Ca2+]i changes caused by O2/glucose depletion.

Conclusions: This work supports a role of L-type Ca2+ channels both in the electrical and ionic changes occurring during the early phases of O2/glucose deprivation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / metabolism*
  • Brain Ischemia / physiopathology*
  • Calcium / metabolism*
  • Calcium Channel Blockers / classification
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / classification
  • Calcium Channels / drug effects
  • Cell Membrane / drug effects
  • Cytophotometry
  • Dantrolene / pharmacology
  • Energy Metabolism
  • Excitatory Amino Acid Antagonists / pharmacology
  • Fluorescent Dyes
  • Fura-2
  • Glucose / metabolism*
  • Male
  • Membrane Potentials / drug effects*
  • Nifedipine / pharmacology
  • Nimodipine / pharmacology
  • Oxygen Consumption / drug effects
  • Pyramidal Cells / drug effects*
  • Pyramidal Cells / metabolism
  • Rats
  • Rats, Wistar
  • Tetrodotoxin / pharmacology
  • Time Factors

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Excitatory Amino Acid Antagonists
  • Fluorescent Dyes
  • Tetrodotoxin
  • Nimodipine
  • Dantrolene
  • Nifedipine
  • Glucose
  • Calcium
  • Fura-2